توقعات سوق المعالجة الحيوية في أمريكا الشمالية حتى عام 2031 - التحليل الإقليمي - حسب المنتج (الأدوات والمواد الاستهلاكية والملحقات)، وحجم التشغيل (العمليات التجارية والعمليات السريرية)، والعملية (المعالجة الحيوية اللاحقة والمعالجة الحيوية السابقة)، والتطبيق (الأجسام المضادة وحيدة النسيلة، واللقاحات، والبروتين المعاد التركيب، والعلاج الخلوي والجين، وغيرها)، والمستخدم النهائي (شركات الأدوية الحيوية، ومنظمة التصنيع التعاقدي، وغيرها)

TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Bioprocessing Market Landscape

4.1 Ecosystem Analysis

4.1.1 List of Vendors in the Value Chain

5. North America Bioprocessing Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Chronic Diseases

5.1.2 Growing Biopharmaceutical Industry

5.2 Market Restraints

5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing

5.3 Market Opportunities

5.3.1 Proliferating Demand for Personalized Medicine

5.4 Future Trends

5.4.1 Shift Toward Automated Cell Therapy Manufacturing

5.5 Impact of Drivers and Restraints:

6. Bioprocessing Market - North America Analysis

6.1 Bioprocessing Market Revenue (US$ Million), 2021-2031

7. North America Bioprocessing Market Analysis - by Product

7.1 Overview

7.2 Instruments

7.2.1 Overview

7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

7.3 Consumables & Accessories

7.3.1 Overview

7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

8. North America Bioprocessing Market Analysis - by Scale of Operation

8.1 Overview

8.2 Commercial Operations

8.2.1 Overview

8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

8.3 Clinical Operations

8.3.1 Overview

8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Bioprocessing Market Analysis - by Process

9.1 Overview

9.2 Downstream Bioprocess

9.2.1 Overview

9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.3 Upstream Bioprocess

9.3.1 Overview

9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Bioprocessing Market Analysis - by Application

10.1 Overview

10.2 Monoclonal Antibodies

10.2.1 Overview

10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.3 Vaccines

10.3.1 Overview

10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.4 Recombinant Protein

10.4.1 Overview

10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.5 Cell & Gene Therapy

10.5.1 Overview

10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Bioprocessing Market Analysis - by End User

11.1 Overview

11.2 Biopharmaceutical Companies

11.2.1 Overview

11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.3 Contract Manufacturing Organization

11.3.1 Overview

11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.4 Others

11.4.1 Overview

11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12. North America Bioprocessing Market - Country Analysis

12.1 North America: Bioprocessing Market Overview

12.1.1 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Country

12.1.1.1 United States: Bioprocessing Market- Revenue and Forecast to 2031 (US$ Million)

12.1.1.2 Overview

12.1.1.3 United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.3.1 United States: Bioprocessing Market Breakdown, by Product

12.1.1.3.1.1 United States: Bioprocessing Market Breakdown, by Instruments

12.1.1.3.1.1.1 United States: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.3.1.1.2 United States: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.3.1.2 United States: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.3.2 United States: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.3.3 United States: Bioprocessing Market Breakdown, by Process

12.1.1.3.4 United States: Bioprocessing Market Breakdown, by Application

12.1.1.3.5 United States: Bioprocessing Market Breakdown, by End User

12.1.1.4 Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.4.1 Overview

12.1.1.5 Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.5.1 Canada: Bioprocessing Market Breakdown, by Product

12.1.1.5.1.1 Canada: Bioprocessing Market Breakdown, by Instruments

12.1.1.5.1.1.1 Canada: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.5.1.1.2 Canada: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.5.1.2 Canada: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.5.2 Canada: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.5.3 Canada: Bioprocessing Market Breakdown, by Process

12.1.1.5.4 Canada: Bioprocessing Market Breakdown, by Application

12.1.1.5.5 Canada: Bioprocessing Market Breakdown, by End User

12.1.1.6 Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.6.1 Overview

12.1.1.7 Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.7.1 Mexico: Bioprocessing Market Breakdown, by Product

12.1.1.7.1.1 Mexico: Bioprocessing Market Breakdown, by Instruments

12.1.1.7.1.1.1 Mexico: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.7.1.1.2 Mexico: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.7.1.2 Mexico: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.7.2 Mexico: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.7.3 Mexico: Bioprocessing Market Breakdown, by Process

12.1.1.7.4 Mexico: Bioprocessing Market Breakdown, by Application

12.1.1.7.5 Mexico: Bioprocessing Market Breakdown, by End User

13. Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Bioprocessing Market

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Getinge AB

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Thermo Fisher Scientific Inc

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Sartorius AG

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Corning Inc

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Bio-Rad Laboratories Inc

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Merck KGaA

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 3M Co

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Eppendorf SE

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Repligen Corp

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Entegris Inc

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Agilent Technologies Inc

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Products and Services

14.11.4 Financial Overview

14.11.5 SWOT Analysis

14.11.6 Key Developments

14.12 Cytiva US LLC

14.12.1 Key Facts

14.12.2 Business Description

14.12.3 Products and Services

14.12.4 Financial Overview

14.12.5 SWOT Analysis

14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

?

List of Tables

Table 1. North America Bioprocessing Market Segmentation

Table 2. List of Vendors

Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

Table 7. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 8. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 9. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 10. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 11. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 12. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 13. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 14. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 15. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 16. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 17. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 18. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 19. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 20. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 21. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 22. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 23. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 24. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 25. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 26. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 27. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 28. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 29. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 30. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 31. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 32. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 33. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 34. Recent Inorganic Growth Strategies in the Bioprocessing Market

Table 35. Recent Organic Growth Strategies in the Bioprocessing Market

Table 36. Glossary of Terms, Bioprocessing Market

?

List of Figures

Figure 1. North America Bioprocessing Market Segmentation, by Country

Figure 2. Bioprocessing Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031

Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)

Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)

Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)

Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)

Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)

Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 24. North America: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)

Figure 25. North America: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 26. United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 27. Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 28. Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 29. Growth Strategies in the Bioprocessing Market

1. Getinge AB
2. Thermo Fisher Scientific Inc
3. Sartorius AG
4. Corning Inc
5. Bio-Rad Laboratories Inc
6. Merck KGaA
7. 3M Co
8. Eppendorf SE
9. Repligen Corp
10. Entegris Inc
11. Agilent Technologies Inc
12. Cytiva US LLC.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America bioprocessing market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the North America bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America bioprocessing market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.